January 2, 2019
March 30, 2023
February 5, 2024
November 14, 2024
At the Nov. 12 Friends of Cancer Research (FOCR) annual meeting, regulators, clinical trialists and industry convened to address ways to boost efficiency in oncology clinical trials and make regulatory processes more efficient. The day was organized around three foundational white papers published by FOCR; AgencyIQ has highlights and takeaways here. The Friends of Cancer…
Read MoreNovember 14, 2024
US President-elect Donald Trump has chosen Robert F. Kennedy Jr., known for his critical stance on vaccines and federal health bodies, as his nominee for Secretary of Health and Human Services (HHS). The news triggered a selloff in vaccine stocks. As the announcement circulated in the final half hour of trading on Thursday, Sanofi saw…
Read MoreNovember 14, 2024
In one of the first appearances since the election of DONALD TRUMP, current FDA Commissioner ROBERT CALIFF weighed in on issues from staffing to final policy priorities at a cancer-focused workshop. AgencyIQ has the highlights. What Califf said at the Friends of Cancer Research annual meeting For now, current FDA Commissioner ROBERT CALIFF will be…
Read MoreNovember 13, 2024
While personally “disappointed” about the election’s outcome, current FDA Commissioner Robert Califf, M.D., has laid out the qualities that he hopes his successor will have. “I think ability to function as an executive is going to be a very important one,” Califf said Tuesday at the Friends of Cancer Research annual meeting. The two-time FDA…
Read MoreNovember 13, 2024
At a Glance Califf emphasized that the agency is focused on its work, despite uncertainty about the incoming administration’s changes. Robert F. Kennedy Jr. criticized the FDA’s nutrition division, but Califf chose not to engage with his remarks. Califf acknowledged that the new administration is expected to implement significant reforms. Earlier this month, Robert F.…
Read MoreNovember 13, 2024
President-elect Donald Trump has announced that biotechnology executive and FDA critic Vivek Ramaswamy, along with controversial businessman Elon Musk, will head a new commission to slash federal regulations and slim down federal government spending, raising further concerns about potential rollbacks of rules and major staff cuts at FDA and other health agencies. Ramaswamy said the…
Read MoreNovember 12, 2024
FDA Commissioner Robert Califf said Tuesday he’s “disappointed” in the presidential election results and acknowledged the uncertainty President-elect Donald Trump’s return to the White House raises for the agency workforce. “We just don’t know what’s going to happen now,” he said during the Friends of Cancer Research annual meeting. ”It’s not correct of me to…
Read MoreNovember 12, 2024
How the US Food and Drug Administration fares during President-elect Donald Trump’s second term will depend, in part, on industry’s support for the agency and its staff, Commissioner Robert Califf told the Friends of Cancer Research annual meeting on 12 November. Califf’s second term as commissioner will end when Trump takes office in January. “This…
Read MoreNovember 12, 2024
WASHINGTON — Food and Drug Administration Commissioner Robert Califf said he’s unsure about the future of the agency under the incoming Trump administration and “disappointed” about the election’s outcome. “I think we just don’t know what’s going to happen,” Califf said at a conference hosted by the nonprofit Friends of Cancer Research on Tuesday. “The gist of…
Read MoreNovember 12, 2024
Robert Califf, commissioner of the US Food and Drug Administration (FDA), said he is “disappointed” in the outcome of the presidential election and warned of potential changes coming to the agency under a second Trump administration. Califf delivered these remarks during the Friends of Cancer Research (FOCR) annual meeting in Washington, DC on Tuesday, where…
Read More
